Venture Capital News and Headlines
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Venture CapitalNewsAzalea Therapeutics Raises $82M in Series A Funding
Azalea Therapeutics Raises $82M in Series A Funding
Venture Capital

Azalea Therapeutics Raises $82M in Series A Funding

•November 4, 2025
0
FinSMEs
FinSMEs•Nov 4, 2025

Why It Matters

The funding validates the emerging in‑vivo gene‑editing CAR‑T model, which could dramatically lower production costs and broaden access to cellular therapies across oncology and autoimmunity. Successful execution would position Azalea as a pioneer in next‑generation precision medicines, reshaping the competitive landscape of cell‑based therapeutics.

Azalea Therapeutics Raises $82M in Series A Funding

Read Original Article
0

Comments

Want to join the conversation?

Loading comments...